Information  X 
Enter a valid email address

Company Name matching 'Vifor Pharma Ltd'

Date
Time Source
Company
Announcement
29 Oct 2018 7:14 am GNW   Vifor Pharma Ltd. PIVOTAL TRIAL CONFIRMS LONG-TERM SAFETY AND EFFICACY OF IV IRON DOSING STRATEGY
20 Sep 2018 5:57 am GNW   Vifor Pharma Ltd. VIFOR PHARMA ANNOUNCES CHANGES IN MANAGEMENT
18 Sep 2018 6:02 am GNW   Vifor Pharma Ltd. VIFOR PHARMA GROUP INCREASES EQUITY INVESTMENT IN CHEMOCENTRYX
28 Aug 2018 4:51 pm GNW   Vifor Pharma Ltd. VIFOR PHARMA ISSUES INAUGURAL CHF 465 MILLION BOND
08 Aug 2018 7:07 am GNW   Vifor Pharma Ltd. CORRECTION (UPDATED LINK): VIFOR PHARMA GROUP REPORTS STRONG H1 2018 RESULTS, RAISES FULL-YEAR GUIDANCE
  6:01 am GNW   Vifor Pharma Ltd. VIFOR PHARMA GROUP REPORTS STRONG H1 2018 RESULTS, RAISES FULL-YEAR GUIDANCE
23 May 2018 6:00 am GNW   Vifor Pharma Ltd. VFMCRP AND CARA THERAPEUTICS TO DEVELOP AND COMMERCIALISE CR845 INJECTION FOR CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS
15 May 2018 5:20 pm GNW   Vifor Pharma Ltd. 90TH VIFOR PHARMA GROUP ANNUAL SHAREHOLDER MEETING
  4:35 pm GNW   Vifor Pharma Ltd. 90TH VIFOR PHARMA GROUP ANNUAL SHAREHOLDER MEETING
08 May 2018 6:02 am GNW   Vifor Pharma Ltd. US FDA APPROVES USE OF VELTASSA® WITH OR WITHOUT FOOD
29 Mar 2018 5:53 am GNW   Vifor Pharma Ltd. VIFOR PHARMA TO PROPOSE JACQUES THEURILLAT AS BOARD MEMBER
27 Mar 2018 5:56 am GNW   Vifor Pharma Ltd. VIFOR PHARMA CONCLUDES LICENSING AGREEMENT WITH ZERIA TO MARKET VELTASSA® IN JAPAN
15 Mar 2018 5:55 am GNW   Vifor Pharma Ltd. VIFOR PHARMA GROUP REPORTS STRONG 2017 RESULTS, EXCEEDING RAISED GUIDANCE
08 Feb 2018 5:58 am GNW   Vifor Pharma Ltd. VIFOR PHARMA FERROPORTIN INHIBITOR ENTERS PHASE-I CLINICAL TRIAL
04 Jan 2018 5:58 am GNW   Vifor Pharma Ltd. AVACOPAN CONDITIONAL MARKETING AUTHORIZATION APPLICATION ACCEPTED FOR REGULATORY REVIEW BY EUROPEAN MEDICINES AGENCY
27 Sep 2017 5:57 am GNW   Vifor Pharma Ltd. VIFOR PHARMA EXPANDS EXCLUSIVE LICENSE AGREEMENT FOR THE COMMERCIALISATION OF MIRCERA® IN THE US
08 Aug 2017 5:55 am GNW   Vifor Pharma Ltd. VIFOR PHARMA REPORTS STRONG H1 2017 RESULTS AND RAISES GUIDANCE
21 Jul 2017 5:59 am GNW   Vifor Pharma Ltd. EUROPEAN COMMISSION APPROVES MARKETING AUTHORISATION FOR VELTASSA®


Company Announcements Archive »

 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t